UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women

Journal of endocrinology, 2004-09, Vol.182 (3), p.399-408

2004

Volltextzugriff (PDF)

Self-perception of fracture risk: what can it tell us?

Osteoporosis international, 2017-12, Vol.28 (12), p.3495-3500

2017

Volltextzugriff (PDF)

Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis

Osteoporosis international, 1999-06, Vol.9 (6), p.489-493

1999

Volltextzugriff (PDF)

Bone metabolism markers and bone mass in healthy pubertal boys and girls

Clinical endocrinology (Oxford), 2002-07, Vol.57 (1), p.107-116

2002

Volltextzugriff (PDF)

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

Bone (New York, N.Y.), 2002-04, Vol.30 (4), p.599-603

2002

Volltextzugriff (PDF)

Reproducibility of bone mineral density measurement in daily practice

Annals of the rheumatic diseases, 2004-03, Vol.63 (3), p.285-289

2004

Volltextzugriff (PDF)

Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells

Journal of endocrinology, 1997-10, Vol.155 (1), p.159

1997

Volltextzugriff (PDF)

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

Clinical science (1979), 2003-07, Vol.105 (1), p.67

2003

Volltextzugriff (PDF)

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3‐Year Randomized Placebo‐Controlled Clinical Trial With a 2‐Year Open Extension

Journal of bone and mineral research, 2002-06, Vol.17 (6), p.1057-1064

2002

Volltextzugriff (PDF)

Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI

NeuroImage (Orlando, Fla.), 2004, Vol.21 (1), p.173-180

2004

Volltextzugriff (PDF)

Estrogen Regulation of Intestinal Calcium Absorption in the Intact and Ovariectomized Adult Rat

Journal of bone and mineral research, 1999-07, Vol.14 (7), p.1197-1202

1999

Volltextzugriff (PDF)

Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

Osteoporosis international, 2005-09, Vol.16 (9), p.1167-1170

2005

Volltextzugriff (PDF)

Risk factors determining active urinary stone formation in patients with urolithiasis

Clinical nephrology, 2005-03, Vol.63 (3), p.188

2005

Volltextzugriff (PDF)

Raloxifene affects brain activation patterns in postmenopausal women during visual encoding

The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1422-1424

2001

Volltextzugriff (PDF)

Pubertal Maturation Characteristics and the Rate of Bone Mass Development Longitudinally Toward Menarche

Journal of bone and mineral research, 2001-04, Vol.16 (4), p.774-781

2001

Volltextzugriff (PDF)

Long‐term effect of calcium supplementation on bone loss in perimenopausal women

Journal of bone and mineral research, 1994-07, Vol.9 (7), p.963-970

1994

Volltextzugriff (PDF)

A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine

Maturitas, 2002-02, Vol.41 (2), p.105-114

2002

Volltextzugriff (PDF)

Oral 17β-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women

Menopause (New York, N.Y.), 2002-05, Vol.9 (3), p.171-178

2002

Volltextzugriff (PDF)

Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: Two randomized, placebo-controlled, 2-year studies

American journal of obstetrics and gynecology, 2002-04, Vol.186 (4), p.729-736

2002

Volltextzugriff (PDF)

The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects

The journal of clinical endocrinology and metabolism, 1988-10, Vol.67 (4), p.644-650

1988

Volltextzugriff (PDF)

Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women

Menopause (New York, N.Y.), 2004-01, Vol.11 (1), p.110-115

2004

Volltextzugriff (PDF)

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age

The journal of clinical endocrinology and metabolism, 1991-09, Vol.73 (3), p.533-540

1991

Volltextzugriff (PDF)

Ultrasound assessment of the endometrium in healthy, asymptomatic early post‐menopausal women: saline infusion sonohysterography versus transvaginal ultrasound

Ultrasound in obstetrics & gynecology, 2000-09, Vol.16 (3), p.254-259

2000

Volltextzugriff (PDF)

Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women

Maturitas, 2005-04, Vol.50 (4), p.312-320

2005

Volltextzugriff (PDF)

Effects of administration of 17β-oestradiol on serum leptin levels in healthy postmenopausal women

Clinical endocrinology (Oxford), 1999-10, Vol.51 (4), p.449-454

1999

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(84)
Science & Technology
(84)
Humans
(77)
Biological And Medical Sciences
(59)
Female
(50)
Medical Sciences
(45)
Endocrinology & Metabolism
(44)
Middle Aged
(41)
Male
(34)
Adult
(30)
Pharmacology. Drug Treatments
(24)
Aged
(21)
Double-Blind Method
(17)
Calcium - Metabolism
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Medical Laboratory Technology
(13)
Animals
(11)
Obstetrics & Gynecology
(11)
Bone And Bones - Metabolism
(10)
Calcium - Urine
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women

Self-perception of fracture risk: what can it tell us?

Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis

Bone metabolism markers and bone mass in healthy pubertal boys and girls

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

Reproducibility of bone mineral density measurement in daily practice

Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3‐Year Randomized Placebo‐Controlled Clinical Trial With a 2‐Year Open Extension

Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI

Estrogen Regulation of Intestinal Calcium Absorption in the Intact and Ovariectomized Adult Rat

Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

Risk factors determining active urinary stone formation in patients with urolithiasis

Raloxifene affects brain activation patterns in postmenopausal women during visual encoding

Pubertal Maturation Characteristics and the Rate of Bone Mass Development Longitudinally Toward Menarche

Long‐term effect of calcium supplementation on bone loss in perimenopausal women

A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine

Oral 17β-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women

Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: Two randomized, placebo-controlled, 2-year studies

The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects

Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age

Ultrasound assessment of the endometrium in healthy, asymptomatic early post‐menopausal women: saline infusion sonohysterography versus transvaginal ultrasound

Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women

Effects of administration of 17β-oestradiol on serum leptin levels in healthy postmenopausal women

Suchergebnisse filtern